Strategic collaborations Texas Biomed actively partners with leading research institutions and industry players (La Jolla Institute, Flyttr, Island Pharmaceuticals, SwRI, DoD CRADA) to advance antiviral therapies, disease countermeasures, and veterinary/public health initiatives, signaling clear opportunities for co-development, licensing, and contract research services.

BSL-4 capabilities Home to the nation’s only privately owned BSL-4 facility, Texas Biomed offers unique high-containment research capacity that can attract government, defense, and pharma partnerships seeking safe study environments for lethal pathogens.

Genomics powerhouse The AT&T Genomics Computing Center and its large-scale HPC cluster positions Texas Biomed as a premier platform for high-throughput genetic and genomic analyses, enabling sales opportunities in data analytics services, cloud-enabled collaborations, and computational biology workloads.

Primate research leadership Operating the Southwest National Primate Research Center with a sizable baboon colony and diverse nonhuman primate resources supports advanced translational studies, offering potential contract research, behavioral/phenotypic studies, and ethically governed preclinical programs.

Defense and public health focus Existing and new CRADAs and government-sponsored programs with DoD and related agencies indicate ongoing demand for medical countermeasures development, emergency preparedness, and high-consequence pathogen research, presenting multi-year collaboration and grant-funded sales avenues.